Preliminary evaluation of F-18 FDG PET findings in pediatric patients with autism

Dr Mai Hong Son1, Dr Le Ngoc Ha1, Dr Vu Duy Chinh2, Dr Nguyen Thanh Liem2
1 Department of Nuclear Medicine Hospital TUQ108
2 International General Hospital Vinmec

Main Article Content

Abstract

Objectives: the purpose of this study was to evaluate F-18 FDG Positron Emission Tomography (PET) findings in pediatric patients with autism.
Subjects and methods: This study includes 15 autism pediatric patients who were diagnosed at the Vinmec international hospital from January 2017 to May 2017 and five oncology patients without neurology’s diseases underwent to whole body PET scan (from vertex to midthigh) were selected as control group. All patients underwent PET/CT brain examination in Nuclear Medicine Department, 108 Central Military Hospital.
Results: Mean patient age (7.1 ± 0.24). On the PET scans of the 15 patients with autism, 13 (86%) had significantly decreased
metabolic activity of both hemispheres. All of the patients had decreased metabolism in temporal, parietal and cingulate gyrus. Mean of Z-scores of autism group showed significantly decreased activity in comparison with Z-score of the control group. There were relations between clinical and grade of hypometabolism of autism.
Conclusions: hypometabolism in the brain of autism pediatric patients may present a role in diagnosis and prognosis.

Article Details

References

1. Kouo JL, Egel AL. The effectiveness of interventions in teaching emotion recognition to children with autism spectrum disorder. Review Journal of Autism and Developmental Disorders. 2016;3(3):254-65.
2. CDC. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites. 2014.
3. Association AP. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSMIV [Internet]. 4th ed. Washington (DC): American Psychiatric Association; 1994 [cited 2010 Mar 8]. 866 p. 4th ed ed.
4. TJ W. The pathogenesis of autism. Clin Med Pathol. 2011;1:99-103.
5. Tashiro Y, Oyabu A, Imura Y, Uchida A, Narita N, Narita M. Morphological abnormalities of embryonic cranial nerves after in utero exposure to valproic acid: implications for the pathogenesis of autism with multiple developmental anomalies. Int J Dev Neurosci. 2011;29(4):359-64.
6. Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Nagren K, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36(12):2103-10.
7. Chivate RS, Thakrar PH, Narang J, Kumar S, Verma M, Patkar D. PET/CT in Autism, A Diagnostic tool. International Journal of Health Sciences and Research. 2016;6(4).
8. Rumsey JM, Duara R, Grady C, Rapoport JL, Margolin RA, Rapoport SI, et al. Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography. Archives of general psychiatry. 1985;42(5):448-55.
9. Dilber C, Caliskan M, Sonmezoglu K, Nisli S, Mukaddes NM, Tatli B, et al. Positron emission tomography findings in children with infantile spasms and autism. J Clin Neurosci. 2013;20(3):373-6.
10. Mitelman SA, Bralet MC, Mehmet Haznedar M, Hollander E, Shihabuddin L, Hazlett EA, et al. Positron emission
tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia. Brain imaging and behavior. 2017.
11. Dichter GS. Functional magnetic resonance imaging of autism spectrum disorders. Dialogues Clin Neurosci. 2012;14(3):319-51.
12. Gupta SK, Ratnam BV. Cerebral perfusion abnormalities in children with autism and mental retardation: a segmental quantitative SPECT study. Indian Pediatr. 2009;46(2):161-4.